Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Feng

Showing results (1251-1260 of 2,038) with videos related to

Pageof 204
Sort By:
Science Translational Medicine|March 4, 2011
Therapeutic targeting of SPINK1-positive prostate cancerBushra Ateeq, Scott A Tomlins, Bharathi Laxman, et al.
Prostate Cancer and Prostatic Diseases|March 9, 2016
Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomyT M Morgan, S R Hawken, K R Ghani, et al.
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 19, 2017
Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumorsX Zhao, S Suryawanshi, M Hruska, et al.
Neoplasia (New York, N.Y.)|December 16, 2014
A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancerRohit Mehra, Yang Shi, Aaron M Udager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT TrialAxel Stenmark Tullberg, Martin Sjöström, Emma Niméus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyRobert B Den, Kasra Yousefi, Edouard J Trabulsi, et al.
Zhonghua Fu Chan Ke Za Zhi|June 4, 2016
[Prenatal diagnosis of chromosome abnormalities and nine microdeletion syndromes using both traditional karyotyping and BoBs]X H Tang, B C Yang, S Zhu, et al.
Antiviral Therapy|April 28, 2006
The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutationsKirsten L White, James M Chen, Joy Y Feng, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 22, 2019
From Antimicrobial to Anticancer Peptides: The Transformation of PeptidesYuan Qin, Zuo D Qin, Jing Chen, et al.
Pageof 204

Showing results (1251-1260 of 2,038) with videos related to

Sort By:
Pageof 204
Science Translational Medicine|March 4, 2011
Therapeutic targeting of SPINK1-positive prostate cancerBushra Ateeq, Scott A Tomlins, Bharathi Laxman, et al.
Prostate Cancer and Prostatic Diseases|March 9, 2016
Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomyT M Morgan, S R Hawken, K R Ghani, et al.
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 19, 2017
Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumorsX Zhao, S Suryawanshi, M Hruska, et al.
Neoplasia (New York, N.Y.)|December 16, 2014
A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancerRohit Mehra, Yang Shi, Aaron M Udager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT TrialAxel Stenmark Tullberg, Martin Sjöström, Emma Niméus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyRobert B Den, Kasra Yousefi, Edouard J Trabulsi, et al.
Zhonghua Fu Chan Ke Za Zhi|June 4, 2016
[Prenatal diagnosis of chromosome abnormalities and nine microdeletion syndromes using both traditional karyotyping and BoBs]X H Tang, B C Yang, S Zhu, et al.
Antiviral Therapy|April 28, 2006
The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutationsKirsten L White, James M Chen, Joy Y Feng, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 22, 2019
From Antimicrobial to Anticancer Peptides: The Transformation of PeptidesYuan Qin, Zuo D Qin, Jing Chen, et al.
Pageof 204